64 studies found for:    Open Studies | "heart transplantation"
Show Display Options
Rank Status Study
21 Recruiting Assessment of Revascularization Versus Conservative Treatment in Heart Transplant Patients for a Clinical Event Reduction
Condition: Heart-lung Transplant Rejection
Interventions: Device: Stent;   Drug: optimal medical therapy
22 Recruiting Magnetic Resonance Elastography of Cardiac Transplant Rejection
Condition: Acute Graft Rejection
Intervention: Device: Magnetic Resonance Elastography driver
23 Recruiting Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients
Conditions: Coronary Disease;   Heart Transplant
Intervention: Biological: Mesenchymal cell therapy
24 Recruiting Impact of Stress Management Training After Cardiac Transplantation
Condition: Heart Transplant
Intervention: Behavioral: Stress management
25 Recruiting Multi-Drug Desensitization Protocol for Heart Transplant Candidates
Conditions: Alloantibodies;   Heart Transplantation;   Immunologic Memory
Intervention: Drug: Bortezomib, Thymoglobulin, (rATG), Rituximab, Gamimune N, (IVIG), Plasmapheresis (Multidrug Protocol)
26 Recruiting Detection of Acute Graft Rejection in Heart Transplant Patients by Estimation of T2
Conditions: Acute Graft Rejection;   Heart Transplantation
Intervention: Device: MRI T2 quantification
27 Unknown  Fish Oil In Heart Transplantation
Condition: Myocardial Tissue in Heart Transplantation
Intervention: Dietary Supplement: Fish Oil
28 Unknown  Coronary Artery Study in Pediatric Heart Transplantation
Condition: Transplant Coronary Artery Disease
29 Recruiting A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo HTx Recipients
Condition: Heart Transplantation
Interventions: Drug: Sandimmun Optoral / Tac + RAD001;   Drug: MPA + RAD001
30 Recruiting Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
Conditions: Heart Failure;   Cardiac Failure;   Congestive Heart Failure;   Heart Failure, Left-sided
Interventions: Device: HeartAssist 5® VAD System;   Device: Control VAD
31 Not yet recruiting On-Line Intervention to Lower Cardiovascular Risk in Pediatric Heart Transplant Patients
Conditions: Vascular; Change;   Dietary Modification;   Physical Activity;   Health Behavior;   Attitude to Health
Intervention: Other: On-Line Diet and Exercise Intervention
32 Unknown  Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy
Conditions: Heart Transplantation;   Cardiac Allograft Vasculopathy;   Cytomegalovirus Infection
Interventions: Drug: Pre-emptive strategy with valganciclovir plus everolimus;   Drug: Prophylaxis with valganciclovir plus mycophenolate;   Drug: Prophylaxis with valganciclovir plus everolimus;   Drug: Pre-emptive mycophenolate
33 Unknown  Medication Adherence Enhancement in Heart Transplant Recipients
Conditions: Medication Adherence;   Self Management;   Rejection
Intervention: Behavioral: behavioral adaptation and symptom management
34 Recruiting Study of Heart Transplant Rejection
Condition: Heart Transplantation
35 Recruiting Early Versus Emergency Left Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation
Condition: End Stage Heart Disease
Intervention: Device: Early VAD implantation
36 Unknown  Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant Recipients
Condition: Heart Transplantation
Intervention: Drug: Bradykinin
37 Unknown  Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients
Condition: Cardiac Transplantation
Intervention: Drug: Daclizumab
38 Unknown  A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)
Condition: Cardiac Allograft Vasculopathy
Intervention: Drug: Thymoglobulin
39 Recruiting Cardiac Allograft Remodeling and Effects of Sirolimus
Conditions: Cardiac Hypertrophy;   Immunosuppression
Interventions: Radiation: Cardiac MRI;   Procedure: Coronary angiography with IVUS;   Other: Cardiac Allograft Remodeling;   Drug: M-TOR Immunosuppression;   Procedure: Cardiac Biopsy C4D stain;   Genetic: Genetic Mechanism of M-TOR;   Other: Cardiopulmonary Exercise Test (CPET)
40 Recruiting Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention: Device: Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years